Evidences from the meriT-V randomized trial on BioMime SES and from MeRes-1 Extend, MeRes100 BRS 1st in man evaluation

This video is offered by Meril Life


Hybrid design: a new world of choice in stents and scaffolds? What is the BioMine Morp or the MeRes 100? What do they have in common with BioMime SES and how do they differ? Join A. Abizaid as he discusses these innovative solutions being developed by Meril Life. From the hybrid design itself– an architecture comprised of more closed cells at the edges of the device and more open cells in the middle – to the latest ongoing trials, first-in-man experience and studies, learn how these new devices can facilitate access, protect against injury and provide new clinical choices in the near future… Watch this three part interview now…